June 30,

September 30,

2026

2025

(in thousands)

Accrued payroll and related expenses

$

4,932

$

6,469

Accrued research and development expenses

2,270

1,800

Accrued professional fees

1,148

1,386

Accrued pharmaceutical drug manufacturing

1,598

2,691

Accrued other

235

405

$

10,183

$

12,751